Elsevier

Biochemical Pharmacology

Volume 70, Issue 7, 1 October 2005, Pages 1088-1095
Biochemical Pharmacology

Up-regulation of Mrp4 expression in kidney of Mrp2-deficient TR rats

https://doi.org/10.1016/j.bcp.2005.06.019Get rights and content

Abstract

Multidrug resistance-associated proteins (Mrps) are a group of ATP-dependent efflux transporters for organic anions. Mrp2 and Mrp4 are co-localized to the apical (brush-border) membrane domain of renal proximal tubules, where they may function together in the urinary excretion of organic anions. Previous reports showed that urinary excretion of some organic anions is not impaired in transport-deficient (TR) rats, which lack Mrp2, suggesting that up-regulation of other transporter(s) may compensate for the loss of Mrp2 function. The purpose of this study was to determine whether Mrp4 expression in kidney is altered in TR rats. Mrp4 mRNA expression was quantified using the high-throughput branched DNA signal amplification assay. Mrp4 protein expression was determined by Western blot and immunohistochemical analysis. Mrp4 mRNA in kidney of TR rats was 100% higher than normal Wistar rats. Western blot analysis showed a 200% increase in Mrp4 protein expression in kidney of the mutant rats compared to normal rats. Immunohistochemical analysis of Mrp4 protein demonstrated apical localization of Mrp4 on renal proximal tubules, and that the immunoreactivity was more intense in kidney sections from TR rats than those from normal rats. In summary, the results of the present study demonstrate that renal Mrp4 expression is up-regulated in TR rats, which may explain why urinary excretion of some organic anions remains normal in the mutant rats.

Introduction

Multidrug resistance-associated proteins (Mrps) are efflux transporters for many structurally diverse amphipathic chemicals and organic anions, including glucuronide conjugates, glutathione S-conjugates, as well as a variety of anticancer drugs (i.e., anthracyclines, vinca alkaloids, and methotrexate) [1]. The human MRP family is currently composed of nine members, MRP1–9. Several Mrps participate in the hepatic efflux transport process. Mrp2 is localized to the canalicular membrane domain of hepatocytes, where it transports organic anion compounds into bile. Deficiency of Mrp2 protein in transport-deficient (TR) rats, as well as in Dubin–Johnson syndrome patients, causes chronic conjugated hyperbilirubinemia [2], [3]. Mrp1, Mrp3, and Mrp4 are localized to the basolateral membrane of hepatocytes. However, under normal physiological conditions, these three basolateral transporters are expressed at relatively low levels in liver of rats [1], [4]. Hepatic expression of Mrp3 is increased in the Mrp2-deficient TR rats [5], as well as in bile-duct ligated rats in which a significant decrease in Mrp2 expression is observed [6], [7]. The inducible nature of rat Mrp3 suggests that in liver, Mrp3 is important in the efflux transport of organic anions under conditions where normal biliary excretory functions are altered.

Mrps are also expressed in kidney, another organ essential for the maintenance of body homeostasis. Both rat and human MRP2 have been shown to localize to the apical (brush-border) membrane of proximal tubular cells, where it may function in the efflux transport of organic anions across the luminal membrane [8], [9]. Despite its low abundance in liver, rat Mrp4 is highly expressed in kidney [4]. Mrp4 sub-cellular localization is unique among the Mrp family of transporters. In renal proximal tubular cells, Mrp4 is found to be localized to the apical membrane domain [10], [11], whereas in hepatocytes, Mrp4 is routed to the basolateral membrane domain [11]. The substrate profile of Mrp4 is also unique in that besides transporting glucuronide- and glutathione S-conjugates [10], Mrp4 also transports cyclic nucleotides and nucleotide analogues [12], [13], [14], which have not been shown to be transported by Mrp1, Mrp2, and Mrp3.

The Mrp2-deficient TR rats are commonly used to examine the role of Mrp2 in the efflux transport of compounds into bile. For example, the findings that organic anions such as cysteinyl leukotrienes [15], acetaminophen–glutathione conjugate [16], reduced and oxidized glutathione [17] are almost absent in bile from TR rats strongly indicate that Mrp2 is the predominant transporter in liver that mediates hepatobiliary transport of these compounds. Interestingly, impaired biliary excretion of cysteinyl leukotrienes [15], [18] and acetaminophen–glucuronide conjugate [16] in TR rats is associated with increased urinary excretion of these compounds. One possible explanation for these finding is that the loss of Mrp2 function may be compensated by (an)other organic anion transporter(s). In light of the fact that Mrp2 and Mrp4 have overlapping substrate profiles, and are co-localized to the apical membrane domain of proximal tubules, we hypothesize that the loss of Mrp2 in TR rats is associated with up-regulation of renal expression of Mrp4, which explains why the capacity for the urinary excretion of some organic anions is retained in TR rats. To test this hypothesis, we compared Mrp4 expression in kidney and liver from normal Wistar and TR rats at both mRNA and protein levels. Mrp4 mRNA levels were quantified using the high-throughput Quantigene® branched DNA (bDNA) signal amplification assay. Mrp4 protein expression was determined by Western blot and immunohistochemical analysis. Hepatic and renal expression of Mrp3 is elevated not only in Mrp2-deficient mutant rats with chronic conjugated hyperbilirubinemia [19], but also in UDP-glucuronosyltransferase (UGT) 1A-deficient Gunn rats with unconjugated hyperbilirubinemia [7], [20]. Therefore, we also compared Mrp4 expression between normal Wistar and Gunn rats. In vitro transport studies showed that Mrp4 transports cAMP [12], [13], [14]. To determine whether changes in Mrp4 expression in renal proximal tubular cells of Mrp2-deficient TR rats alter urinary excretion of endogenous cAMP, cAMP levels in urine and kidney tissue extracts from normal Wistar and TR rats were compared.

Section snippets

Materials

The anti-human MRP4 polyclonal antibody was obtained from Alexis Biochemicals (Lausen, Switzerland). Vectastain Elite ABC kit for rat IgG and Avidin/Biotin blocking kit were purchased from Vector Laboratories (Burlingame, CA, USA). HistoMark Black Substrate system was purchased from Kierkegaard and Perry Laboratories (Gaithersburg, MD, USA). Donkey anti-rabbit horseradish peroxidase-linked antibodies were from Amersham Life Science (Arlington Heights, IL, USA). A rat Mrp4 peptide (20 amino acid

Mrp4 mRNA expression in Mrp2-deficient TR rats

As shown in Fig. 1, mRNA of Mrp4 was much more abundant in kidney than in liver. Mrp4 expression in both kidney and liver of Mrp2-deficient TR rats was about twice that of Wistar rats.

Western blot analysis of Mrp4 protein expression in Mrp2-deficient TR rats

To determine whether the differences in Mrp4 mRNA expression translate into corresponding changes in Mrp4 protein, membrane fractions were prepared from kidney and liver of both strains of rats and Western blot analysis was performed using polyclonal anti-human MRP4 antibody as primary antibody. The peptide

Discussion

The data from the present study demonstrate that renal Mrp4 expression is significantly increased in Mrp2-deficient TR rats compared to normal Wistar rats (Fig. 1, Fig. 2). Our immunohistochemical analysis of Mrp4 expression (Fig. 3) shows that (1) immunostaining is localized to the apical membrane domain of proximal tubules, and (2) staining intensity in kidney of TR rats is higher than that in normal Wistar rats. These results strongly suggest that Mrp4 functions as an efflux transporter

Acknowledgement

This work was funded by grants from National Institute of Health (ES-09716 and ES-07079).

References (35)

  • C.C. Paulusma et al.

    Congenital jaundice in rats with a mutation in a multidrug resistance-associated protein gene

    Science

    (1996)
  • C.C. Paulusma et al.

    A mutation in the human canalicular multispecific organic anion transporter gene causes the Dubin–Johnson syndrome

    Hepatology

    (1997)
  • H. Xiong et al.

    Mechanisms of impaired biliary excretion of acetaminophen glucuronide after acute phenobarbital treatment or phenobarbital pretreatment

    Drug Metab Dispos

    (2002)
  • K. Ogawa et al.

    Characterization of inducible nature of MRP3 in rat liver

    Am J Physiol Gastrointest Liver Physiol

    (2000)
  • T.P. Schaub et al.

    Expression of the conjugate export pump encoded by the mrp2 gene in the apical membrane of kidney proximal tubules

    J Am Soc Nephrol

    (1997)
  • T.P. Schaub et al.

    Expression of the MRP2 gene-encoded conjugate export pump in human kidney proximal tubules and in renal cell carcinoma

    J Am Soc Nephrol

    (1999)
  • R.A. van Aubel et al.

    The MRP4/ABCC4 gene encodes a novel apical organic anion transporter in human kidney proximal tubules: putative efflux pump for urinary cAMP and cGMP

    J Am Soc Nephrol

    (2002)
  • Cited by (50)

    • Multidrug resistance-associated protein 4 in pharmacology: Overview of its contribution to pharmacokinetics, pharmacodynamics and pharmacogenetics

      2019, Life Sciences
      Citation Excerpt :

      In the case of PMEA (9-(2-phosphonylmethoxyethyl)adenine)), initially described as a MRP4 substrate, an up regulation of BCRP in various tissues was described in MRP4 Knock Out mice and was associated with decreased tissue concentrations of PMEA [59]. Based on this observation, it has been confirmed that BCRP transports and confers resistance to the purine prodrug Bis(POM)PMEA also known as adefovir dipivoxil used in treatment for Hepatitis B. MRP4 expression in kidneys was also found to be increased in MRP2 deficient rats strain as compared to wild type rats but the efflux of cAMP (a MRP4 substrate) was not increased [60]. Both of these transporters are expressed at the apical membranes of proximal tubule cells and this study suggested that MRP4 can take over MRP2 substrates but it has not been tested with common substrates of these transporters.

    • Toxicological potential of acyl glucuronides and its assessment

      2017, Drug Metabolism and Pharmacokinetics
      Citation Excerpt :

      In studies using gene knockout (or deficient) animals, genes other than the target gene may be up- or down-regulated. For example, up-regulation of Mrp3 and Mrp4 is observed in Mrp2-deficient rats [113,114]. An animal model of AG-induced toxicity using normal laboratory animals would be useful for understanding the mechanisms of AG toxicity.

    • Quantification of biliary excretion and sinusoidal excretion of 5(6)-carboxy-2',7'-dichlorofluorescein (CDF) in cultured hepatocytes isolated from Sprague Dawley, Wistar and Mrp2-deficient Wistar (TR<sup>-</sup>) rats

      2014, Toxicology in Vitro
      Citation Excerpt :

      We have shown that the down-regulation of abcc2 in the TR− rats is compensated for by a 2.5-fold increase in abcc3 (Mrp3) expression. The increase in abcc3 expression in TR− rats is believed to be in response to the down-regulation of abcc2 with similar reports of rat Mrp3 up-regulation in previous studies reported elsewhere (Chen et al., 2005; Johnson et al., 2006). The up-regulation of abcc3 appears to evoke a compensatory increase in efflux at the sinusoidal membrane and a previous study using radio-labelled gemfibrozil administered to TR− and Wistar rats have revealed altered disposition and tissue distribution of this substrate in the Mrp2-deficient rat strain (Kim et al., 2003).

    • Luteolin ameliorates cisplatin-induced nephrotoxicity in mice through inhibition of platinum accumulation, inflammation and apoptosis in the kidney

      2013, Toxicology
      Citation Excerpt :

      Although the precise mechanism of CP nephrotoxicity is not yet fully understood, Aleksunes et al. (2008) showed that CP dose-dependently increases expression of plasma-membrane transporters, particularly MRP2 and MRP4. In the kidney, MRP2 and MRP4 are localized to the apical membrane of renal proximal tubule cells (Chen et al., 2005; König et al., 1999). These proteins act as drug-efflux transporters in various cells and are responsible for multidrug resistance by limiting bioavailability and facilitating biliary and renal excretion of their substrates, including CP (Borst et al., 2000).

    • Placental and fetal disposition of mercuric ions in rats exposed to methylmercury: Role of Mrp2

      2012, Reproductive Toxicology
      Citation Excerpt :

      Although the reason for this finding is unclear at present, one possible explanation is that upregulation of basolateral transporters in TR− rats may facilitate or enhance movement of mercuric ions from within target cells into blood. Alterations in the expression of selected transporters, such as Mrp3, have been shown to occur in TR− rats [46–48]; however, none of the transport proteins that have been shown to be affected in TR− rats have been identified as carriers of mercuric species. Additional studies are clearly needed to elucidate additional mechanisms involved in the transport of mercury and to understand changes in the expression of these transport proteins.

    View all citing articles on Scopus
    View full text